Market Overview

Novadaq 'Positioned For A Strong Run'; Canaccord Reiterates Buy

Share:

Canaccord's Jason Mills reiterated Novadaq Technologies Inc. (NASDAQ: NVDQ)'s Buy rating with an unchanged price target of $15. The reiteration came after Canaccord met with Novadaq's CEO and CFO.

After meeting management, Mills "came away even more bullish on the company's growth prospects and upside potential" and was especially impressed with the company's portfolio. "Novadaq's broad, synergistic product portfolio, coupled with its large and growing direct sales force… [will lead] to profitability without the need for additional capital," said Mills.

Most notable of Novadaq's portfolio included:

  • The company's proprietary fluorescent imaging platform, "which has yet to challenge by a viable competitor."
  • DermAcell tissue matrix, which targets breast reconstruction and wound care.
  • New imaging molecules which "are expected to be announced at the company's analyst meeting in November."

All three of these products could be at least a material near-term of long-term growth driver said the analyst.

At time of writing, Novadaq traded at $10.94.

Latest Ratings for NVDQ

DateFirmActionFromTo
Jul 2017DowngradesOutperformSector Perform
Jul 2017DowngradesMarket OutperformMarket Perform
Jul 2017DowngradesBuyHold

View More Analyst Ratings for NVDQ
View the Latest Analyst Ratings

Posted-In: Canaccord Jason MillsAnalyst Color Reiteration Analyst Ratings

 

Related Articles (NVDQ)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VBTXRaymond JamesMaintains28.0
IRBTPiper JaffrayReiterates51.0
KMBMorgan StanleyMaintains139.0
SNAPNomuraMaintains16.0
DFSCredit SuisseMaintains99.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Aussie News Triggers A Nighttime Trade For the AUD/USD Using Spreads

Will Canada Goose Be More Than Outerwear?